Status:
COMPLETED
Methylphenidate Hydrochloride Controlled-Release Tablets Augmentation Strategy for Patients With Obsessive Compulsive Disorder
Lead Sponsor:
Guangdong Provincial People's Hospital
Conditions:
Obsessive Compulsive Disorder
Eligibility:
All Genders
18-40 years
Phase:
PHASE4
Brief Summary
Explore the efficacy of methylphenidate hydrochloride controlled-release tablets add-on pharmacotherapy on clinical symptomatology and cognitive functioning in a sample of patients with obsessive-comp...
Eligibility Criteria
Inclusion
- Informed consent
- Met DSM-V criteria
- Y-BOCS ≥ 16
- Course of illness ≥ 1year
- Age range between 18\~40 years old
- Junior high school education level above
Exclusion
- Any other psychiatric axis-I or axis-II disorders
- History of epileptic seizures or any other neurological disorder
- Any other clinically relevant abnormalities in their medical history or laboratory examinations; alcohol or drug abuser
Key Trial Info
Start Date :
October 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2015
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT02194075
Start Date
October 1 2013
End Date
October 1 2015
Last Update
October 23 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Guangdong General Hospital, Guangdong academy of medical science
Guangzhou, Guangdong, China, 510180